Emerging ciprofloxacin-resistant Pseudomonas aeruginosa

American Journal of Ophthalmology

Volumn 128, Issue 4, 1999, Pages 509-510

  Chaudhry, Nauman A ^a   Flynn Jr, Harry W ^a   Murray, Timothy G ^a   Tabandeh, Homayoun ^a   Mello Jr, Mozart O ^a   Miller, Darlene ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CEFTAZIDIME; CHLORAMPHENICOL ACETYLTRANSFERASE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SHORT SURVEY;

EID: 0032880618     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00196-8     Document Type: Article

References (6)

1. Wilhelmus K.R., Hyndiuk R.A., Caldwell D.R., et al. 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. Arch Ophthalmol. 111:1993;1210-1218.
2. Chaudhry N.A., Tabandeh H., Rosenfeld P.J., Smith D., Davis J. Scleral buckle infection with ciprofloxacin-resistant Pseudomonas aeruginosa. Arch Ophthalmol. 116:1998;1251.
3. Snyder M.E., Katz H.R. Ciprofloxacin-resistant bacterial keratitis. Am J Ophthalmol. 114:1992;336-338.
4. Knauf H.P., Silvany R., Southern P.M., Risser R.C., Wilson S.E. Susceptibility of corneal and conjunctival pathogens to ciprofloxacin. Cornea. 15:1996;66-71.
5. Kunimoto D.Y., Sharma S., Garg P., Rao G.N. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin emerging resistance . Ophthalmology. 106:1999;80-85.
6. Lorian V. Antibiotics in laboratory medicine. ed 4. 1996;478 Williams & Wilkins, Baltimore.